Clinical Trial Update: Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC) [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating ATH-063 for efficacy and safety in relapsed/refractory moderately to severely active ulcerative colitis, with the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Ulcerative Colitis

Drugs mentioned

• ATH-063

Snippet

Sponsor: Athos Therapeutics Inc | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Status: NOT_YET_RECRUITING